Literature DB >> 14115686

ONCOLYSIS BY CLOSTRIDIA. I. ACTIVITY OF CLOSTRIDIUM BUTYRICUM (M-55) AND OTHER NONPATHOGENIC CLOSTRIDIA AGAINST THE EHRLICH CARCINOMA.

J R MOESE, G MOESE.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CLOSTRIDIUM; EXPERIMENTAL LAB STUDY; MICE; NEOPLASMS, EXPERIMENTAL; RATS

Mesh:

Substances:

Year:  1964        PMID: 14115686

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  36 in total

Review 1.  Use of preferentially replicating bacteria for the treatment of cancer.

Authors:  M Sznol; S L Lin; D Bermudes; L M Zheng; I King
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model.

Authors:  Masashi Momiyama; Ming Zhao; Hiroaki Kimura; Benjamin Tran; Takashi Chishima; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

3.  Advances in bacterial cancer therapies using synthetic biology.

Authors:  Tiffany Chien; Anjali Doshi; Tal Danino
Journal:  Curr Opin Syst Biol       Date:  2017-05-23

Review 4.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

5.  [The use of spores of bacteria for a serological tumour-diagnosis (I)].

Authors:  J R Möse
Journal:  Z Krebsforsch       Date:  1970-03-10

6.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.

Authors:  Clinton Yam; Ming Zhao; Katsuhiro Hayashi; Huaiyu Ma; Hiroyuki Kishimoto; Michele McElroy; Michael Bouvet; Robert M Hoffman
Journal:  J Surg Res       Date:  2009-03-31       Impact factor: 2.192

Review 8.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

9.  Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.

Authors:  H Kimura; L Zhang; M Zhao; K Hayashi; H Tsuchiya; K Tomita; M Bouvet; J Wessels; R M Hoffman
Journal:  Cell Prolif       Date:  2009-11-18       Impact factor: 6.831

10.  Tumor-targeted delivery of biologically active TRAIL protein.

Authors:  H-Y Zhang; J-H Man; B Liang; T Zhou; C-H Wang; T Li; H-Y Li; W-H Li; B-F Jin; P-J Zhang; J Zhao; X Pan; K He; W-L Gong; X-M Zhang; A-L Li
Journal:  Cancer Gene Ther       Date:  2010-01-15       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.